Overview of age-variations
Age group comparisons |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
18384253 |
Age 24.5 ± 3, Gender ⚥ |
0.97 (mean value of the compound area) |
LC-MS; GC-MS |
plasma |
18384253 |
Age 40.8 ± 5.6, Gender ⚥ |
1.0 (mean value of the compound area) |
LC-MS; GC-MS |
plasma |
18384253 |
Age 55.6 ± 3.7, Gender ⚥ |
1.06 (mean value of the compound area) |
LC-MS; GC-MS |
plasma |
30113646 |
Age 44.6 ± 14, Gender ♀ (Dutch) |
51.9 (μmol/L) |
LC-MS/MS |
plasma |
30113646 |
Age 44.6 ± 13, Gender ♀ (South-Asian Surinamese) |
57.1 (μmol/L) |
LC-MS/MS |
plasma |
30113646 |
Age 44.6 ± 14, Gender ♀ (Dutch) |
105.9 (% (percentage of metabolite concentration compared with baseline (100%) per 10 year increment in age; analyses were adjusted for BMI)) |
LC-MS/MS |
plasma |
30113646 |
Age 44.6 ± 13, Gender ♀ (South-Asian Surinamese) |
104.1 (% (percentage of metabolite concentration compared with baseline (100%) per 10 year increment in age; analyses were adjusted for BMI)) |
LC-MS/MS |
plasma |
27374292 |
Age [25–35] (median=32), Gender ♂ (Japanese) |
0.988592 (average level of metabolite) |
UHPLC-MS/MS Positive mode |
serum |
27374292 |
Age [55–64] (median=60), Gender ♂ (Japanese) |
1.126958 (average level of metabolite) |
UHPLC-MS/MS Positive mode |
serum |
Linear regression |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
30841604 |
Age [25-74], Gender ♀ |
0.11 (β) |
indirect potentiometry |
serum |
30841604 |
Age [45-80], Gender ♀ |
0.05 (β) |
FIA-ESI-MS/MS |
serum |
log2 ratio/log2(FC) |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
29090929 |
Age 42 ± 12, Gender ♀ |
-0.319 (log2 ratio) |
NMR |
blood |
29090929 |
Age 41 ± 12, Gender ♂ |
-0.124 (log2 ratio) |
NMR |
blood |